DXCM : DexCom stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2025-04-17 |
|---|---|---|---|---|
| 2025 | $74.0 | $67.95 | $81.2 | 7.92% |
| 2026 | $183.48 | $85.62 | $293.43 | 167.59% |
| 2027 | $308.66 | $300.22 | $313.05 | 350.14% |
| 2028 | $275.37 | $261.86 | $299.29 | 301.59% |
| 2029 | $263.84 | $262.13 | $264.62 | 284.78% |
| 2030 | $251.93 | $242.77 | $262.71 | 267.41% |
| 2031 | $234.22 | $223.88 | $245.65 | 241.58% |
| 2032 | $216.38 | $208.08 | $222.95 | 215.56% |
| 2033 | $199.85 | $193.79 | $206.56 | 191.46% |
| 2034 | $189.63 | $188.06 | $192.85 | 176.54% |
| 2035 | $188.72 | $188.15 | $189.56 | 175.22% |
The 16 Wall Street analysts offering DexCom stock forecast in the last 6 months have average price target of
$96.5 with a high forecast of $115.0 and a low forecast of $82.0.
The average DexCom stock forecast represents a 40.73%
increase from the last price of $68.56999969482422.
For DexCom stock forecast for 2025, 8 predictions are offered for each month of 2025 with average DexCom stock
forecast of $74.0, a high forecast of $81.2, and a low forecast of $67.95.
The average DexCom stock forecast 2025 represents a 7.92%
increase from the last price of $68.56999969482422.
For DexCom stock forecast for 2026, 12 predictions are offered for each month of 2026 with average DexCom stock
forecast of $183.48, a high forecast of $293.43, and a low forecast of $85.62.
The average DexCom stock forecast 2026 represents a 167.59%
increase from the last price of $68.56999969482422.
For DexCom stock forecast for 2028, 12 predictions are offered for each month of 2028 with average DexCom stock
forecast of $275.37, a high forecast of $299.29, and a low forecast of $261.86.
The average DexCom stock forecast 2028 represents a 301.59%
increase from the last price of $68.56999969482422.
For DexCom stock forecast for 2030 (5 year), 12 predictions are offered for each month of 2030 with average DexCom stock
forecast of $251.93, a high forecast of $262.71, and a low forecast of $242.77.
The average DexCom stock forecast 2030 represents a 267.41%
increase from the last price of $68.56999969482422.
For DexCom stock forecast 2031, 12 predictions are offered for each month of 2031 with average DexCom stock
forecast of $234.22, a high forecast of $245.65, and a low forecast of $223.88.
The average DexCom stock forecast 2031 represents a 241.58%
increase from the last price of $68.56999969482422.
For DexCom stock forecast for 2035 (10 year), 4 predictions are offered for each month of 2035 with average DexCom stock
forecast of $188.72, a high forecast of $189.56, and a low forecast of $188.15.
The average DexCom stock forecast 2035 represents a 175.22%
increase from the last price of $68.56999969482422.
Please, see more forecasts below.
DXCM : DexCom stock forecast by Wall Street Analysts
The average DexCom stock forecast from last 6 month is $96.5, and this show a 5.19% increase in average from the prior price target of the each prediction. Also, this average forecast of $96.5 represents a -11.21% decrease from the past average forecast of $108.68, 6 months ago from 22 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2025-04-10 | Mizuho | $85.0000 | Outperform | |
| 2025-03-04 | Citigroup | $101.0000 | $104.0000 | Buy |
| 2025-02-14 | Morgan Stanley | $75.00 | $82 | Equal-Weight |
| 2025-02-14 | Canaccord Genuity | $99.00 | $103.0000 | Buy |
| 2025-02-03 | Redburn Atlantic | $85.0000 | $115.0000 | Buy |
| 2025-01-16 | Baird | $86.0000 | $104 | Outperform |
| 2024-12-11 | Wells Fargo | $90.00 | $94.0000 | Overweight |
| 2024-12-11 | Citigroup | $85.0000 | $91.0000 | Buy |
| 2024-12-09 | Canaccord Genuity | $89.00 | $99.0000 | Buy |
| 2024-10-25 | Wells Fargo | $80.00 | $90.0000 | Overweight |
| 2024-10-25 | Leerink Partners | $90.0000 | $87 | Outperform |
| 2024-10-25 | JP Morgan | $75.00 | $85.0000 | Neutral |
| 2024-10-25 | Oppenheimer | $115.00 | $105.0000 | Outperform |
| 2024-10-25 | RBC Capital | $120.00 | $115 | Outperform |
| 2024-10-25 | Raymond James | $115.0000 | $99 | Strong Buy |
| 2024-10-25 | Bernstein | $82.0000 | $86.0000 | Outperform |
| 2024-10-08 | RBC Capital | $130.0000 | $120.0000 | Outperform |
| 2024-08-26 | Piper Sandler | $90.00 | $90 | Overweight |
| 2024-08-23 | Stifel | $90.00 | $100 | Buy |
| 2024-08-05 | Baird | $80.00 | $82 | Neutral |
| 2024-07-29 | Barclays | $138.00 | $113.0000 | Equal-Weight |
| 2024-07-26 | Baird | $161.0000 | $80.0000 | Neutral |
| 2024-07-26 | BTIG | $156.0000 | $120.0000 | Buy |
| 2024-07-26 | Morgan Stanley | $120.00 | $75 | Equal-Weight |
| 2024-07-26 | Oppenheimer | $150.0000 | $115.0000 | Outperform |
| 2024-07-26 | UBS | $163.0000 | $95.0000 | Buy |
| 2024-07-26 | Stifel | $132.00 | $90 | Buy |
| 2024-07-26 | Piper Sandler | $150.00 | $90 | Overweight |
| 2024-07-26 | RBC Capital | $165.00 | $145 | Outperform |
| 2024-07-26 | Wells Fargo | $145.0000 | $80.0000 | Overweight |
| 2024-07-26 | Canaccord Genuity | $145.00 | $89.0000 | Buy |
| 2024-07-26 | JP Morgan | $145.0000 | $75.0000 | Neutral |
| 2024-07-23 | Canaccord Genuity | $145.00 | $145.0000 | Buy |
| 2024-07-15 | Morgan Stanley | $132.0000 | $120 | Equal-Weight |
| 2024-07-12 | Stifel | $145.00 | $132 | Buy |
| 2024-05-30 | Redburn Atlantic | $130.0000 | Neutral | |
| 2024-04-26 | Raymond James | $151.00 | $160 | Strong Buy |
| 2024-04-26 | Canaccord Genuity | $144.0000 | $145.0000 | Buy |
DexCom stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2025-04-21 | $69.49 | 1.35% |
| 2025-04-22 | $67.38 | -3.05% |
| 2025-04-23 | $65.82 | -2.30% |
| 2025-04-24 | $65.71 | -0.17% |
| 2025-04-25 | $64.00 | -2.61% |
DXCM : Long term DexCom stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2025 May. is $67.95 , for 2026 Apr. is $119.65 , for 2029 Apr. is $263.83 , for 2030 Apr. is $260.01 , for 2034 Apr. is $190.43 , and for 2035 Apr. is $189.56.
DXCM : DexCom stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 May. | $67.95 | -0.90% |
| 2025 Jun. | $68.91 | 1.40% |
| 2025 Jul. | $70.53 | 2.36% |
| 2025 Aug. | $72.52 | 2.83% |
| 2025 Sep. | $75.04 | 3.47% |
| 2025 Oct. | $76.84 | 2.40% |
| 2025 Nov. | $79.00 | 2.80% |
| 2025 Dec. | $81.20 | 2.79% |
DXCM : DexCom stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $85.62 | 5.44% |
| 2026 Feb. | $92.81 | 8.40% |
| 2026 Mar. | $103.95 | 12.00% |
| 2026 Apr. | $119.65 | 15.10% |
| 2026 May. | $137.96 | 15.30% |
| 2026 Jun. | $162.10 | 17.50% |
| 2026 Jul. | $190.24 | 17.36% |
| 2026 Aug. | $219.48 | 15.37% |
| 2026 Sep. | $246.05 | 12.10% |
| 2026 Oct. | $267.43 | 8.69% |
| 2026 Nov. | $283.10 | 5.86% |
| 2026 Dec. | $293.43 | 3.65% |
DXCM : DexCom stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $300.22 | 2.32% |
| 2027 Feb. | $304.67 | 1.48% |
| 2027 Mar. | $307.57 | 0.95% |
| 2027 Apr. | $309.61 | 0.66% |
| 2027 May. | $311.12 | 0.49% |
| 2027 Jun. | $312.19 | 0.34% |
| 2027 Jul. | $312.85 | 0.21% |
| 2027 Aug. | $313.05 | 0.06% |
| 2027 Sep. | $312.75 | -0.10% |
| 2027 Oct. | $310.11 | -0.84% |
| 2027 Nov. | $306.69 | -1.10% |
| 2027 Dec. | $303.13 | -1.16% |
DXCM : DexCom stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $299.29 | -1.27% |
| 2028 Feb. | $294.76 | -1.51% |
| 2028 Mar. | $289.16 | -1.90% |
| 2028 Apr. | $282.98 | -2.14% |
| 2028 May. | $277.55 | -1.92% |
| 2028 Jun. | $273.40 | -1.50% |
| 2028 Jul. | $269.99 | -1.25% |
| 2028 Aug. | $266.76 | -1.20% |
| 2028 Sep. | $264.14 | -0.98% |
| 2028 Oct. | $262.60 | -0.58% |
| 2028 Nov. | $261.94 | -0.25% |
| 2028 Dec. | $261.86 | -0.03% |
DXCM : DexCom stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $262.13 | 0.11% |
| 2029 Feb. | $262.70 | 0.22% |
| 2029 Mar. | $263.36 | 0.25% |
| 2029 Apr. | $263.83 | 0.18% |
| 2029 May. | $264.14 | 0.12% |
| 2029 Jun. | $264.40 | 0.10% |
| 2029 Jul. | $264.57 | 0.06% |
| 2029 Aug. | $264.62 | 0.02% |
| 2029 Sep. | $264.55 | -0.03% |
| 2029 Oct. | $264.36 | -0.07% |
| 2029 Nov. | $264.00 | -0.14% |
| 2029 Dec. | $263.43 | -0.22% |
DXCM : DexCom stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $262.71 | -0.27% |
| 2030 Feb. | $262.16 | -0.21% |
| 2030 Mar. | $261.93 | -0.09% |
| 2030 Apr. | $260.01 | -0.73% |
| 2030 May. | $253.97 | -2.32% |
| 2030 Jun. | $251.22 | -1.08% |
| 2030 Jul. | $249.11 | -0.84% |
| 2030 Aug. | $246.95 | -0.87% |
| 2030 Sep. | $245.01 | -0.78% |
| 2030 Oct. | $243.50 | -0.62% |
| 2030 Nov. | $242.77 | -0.30% |
| 2030 Dec. | $243.85 | 0.44% |
DXCM : DexCom stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $245.65 | 0.74% |
| 2031 Feb. | $245.09 | -0.23% |
| 2031 Mar. | $242.65 | -1.00% |
| 2031 Apr. | $239.79 | -1.18% |
| 2031 May. | $237.05 | -1.15% |
| 2031 Jun. | $234.49 | -1.08% |
| 2031 Jul. | $232.16 | -0.99% |
| 2031 Aug. | $230.07 | -0.90% |
| 2031 Sep. | $228.21 | -0.81% |
| 2031 Oct. | $226.55 | -0.73% |
| 2031 Nov. | $225.10 | -0.64% |
| 2031 Dec. | $223.88 | -0.54% |
DXCM : DexCom stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $222.95 | -0.41% |
| 2032 Feb. | $222.26 | -0.31% |
| 2032 Mar. | $221.39 | -0.39% |
| 2032 Apr. | $220.23 | -0.52% |
| 2032 May. | $218.95 | -0.58% |
| 2032 Jun. | $217.61 | -0.61% |
| 2032 Jul. | $216.20 | -0.65% |
| 2032 Aug. | $214.68 | -0.70% |
| 2032 Sep. | $213.08 | -0.75% |
| 2032 Oct. | $211.41 | -0.78% |
| 2032 Nov. | $209.72 | -0.80% |
| 2032 Dec. | $208.08 | -0.78% |
DXCM : DexCom stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $206.56 | -0.73% |
| 2033 Feb. | $205.14 | -0.69% |
| 2033 Mar. | $203.82 | -0.64% |
| 2033 Apr. | $202.58 | -0.61% |
| 2033 May. | $201.39 | -0.59% |
| 2033 Jun. | $200.25 | -0.57% |
| 2033 Jul. | $199.13 | -0.56% |
| 2033 Aug. | $198.03 | -0.55% |
| 2033 Sep. | $196.92 | -0.56% |
| 2033 Oct. | $195.84 | -0.55% |
| 2033 Nov. | $194.79 | -0.53% |
| 2033 Dec. | $193.79 | -0.52% |
DXCM : DexCom stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $192.85 | -0.49% |
| 2034 Feb. | $191.96 | -0.46% |
| 2034 Mar. | $191.15 | -0.42% |
| 2034 Apr. | $190.43 | -0.38% |
| 2034 May. | $189.80 | -0.33% |
| 2034 Jun. | $189.28 | -0.27% |
| 2034 Jul. | $188.88 | -0.21% |
| 2034 Aug. | $188.57 | -0.16% |
| 2034 Sep. | $188.32 | -0.13% |
| 2034 Oct. | $188.15 | -0.09% |
| 2034 Nov. | $188.06 | -0.05% |
| 2034 Dec. | $188.06 | 0.00% |
DXCM : DexCom stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $188.15 | 0.05% |
| 2035 Feb. | $188.37 | 0.12% |
| 2035 Mar. | $188.79 | 0.23% |
| 2035 Apr. | $189.56 | 0.41% |
Financial Data for DexCom stock
Frequently Asked Questions about DexCom stock forecast
Is DexCom a good long term stock?
From DexCom stock forecast , DexCom (DXCM) stock cannot be a good investment choice. According to AIPickup, the DexCom stock price forecast for 2025 May. is $67.95483633348599 From DexCom stock forecast , DexCom (DXCM) stock can be a good investment choice. According to AIPickup, the DexCom stock price forecast for 2026 Apr. is $119.64872232043406 From DexCom stock forecast , DexCom (DXCM) stock can be a good investment choice. According to AIPickup, the DexCom stock price forecast for 2029 Apr. is $263.829659274532 From DexCom stock forecast , DexCom (DXCM) stock can be a good investment choice. According to AIPickup, the DexCom stock price forecast for 2030 Apr. is $260.00941691752274 From DexCom stock forecast , DexCom (DXCM) stock can be a good investment choice. According to AIPickup, the DexCom stock price forecast for 2034 Apr. is $190.4254324414101 From DexCom stock forecast , DexCom (DXCM) stock can be a good investment choice. According to AIPickup, the DexCom stock price forecast for 2035 Apr. is $189.56413699475468
Is DexCom stock overvalued?
DexCom (DXCM) stock is expected to go UP . Therefore, AIPickup would say that DexCom (DXCM) stock is NOT overvalued.
Will DexCom stock price go up?
Yes. The DexCom stock price forecast for 2026 Apr. is $119.64872232043406
Is DexCom stock a good buy now?
Since closing price on 2025-04-17 is $68.56999969482422 and forecast for 2026 Apr. is $119.65, DexCom stock is a good 1 year investment.
14 Days Historical Data for DexCom stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| DXCM stock price for 2025-03-31 | $68.29 | $67.22 | $66.25 | $68.75 |
| DXCM stock price for 2025-04-01 | $67.32 | $67.85 | $66.30 | $68.40 |
| DXCM stock price for 2025-04-02 | $68.14 | $66.32 | $66.32 | $68.52 |
| DXCM stock price for 2025-04-03 | $61.80 | $64.89 | $61.48 | $65.01 |
| DXCM stock price for 2025-04-04 | $59.83 | $59.63 | $57.52 | $61.05 |
| DXCM stock price for 2025-04-07 | $61.63 | $58.03 | $58.00 | $62.90 |
| DXCM stock price for 2025-04-08 | $60.69 | $62.50 | $59.97 | $63.89 |
| DXCM stock price for 2025-04-09 | $66.84 | $60.09 | $59.62 | $67.63 |
| DXCM stock price for 2025-04-10 | $67.30 | $72.80 | $66.46 | $73.50 |
| DXCM stock price for 2025-04-11 | $66.14 | $67.23 | $64.99 | $67.66 |
| DXCM stock price for 2025-04-14 | $67.39 | $67.28 | $66.41 | $68.07 |
| DXCM stock price for 2025-04-15 | $69.23 | $67.40 | $66.98 | $69.32 |
| DXCM stock price for 2025-04-16 | $68.73 | $68.84 | $67.75 | $69.69 |
| DXCM stock price for 2025-04-17 | $68.57 | $67.00 | $66.53 | $68.78 |